4//SEC Filing
McFarlane Neil F. 4
Accession 0001437749-25-004067
CIK 0001434647other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:54 PM ET
Size
6.1 KB
Accession
0001437749-25-004067
Insider Transaction Report
Form 4
McFarlane Neil F.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-02-13$7.86/sh−61,273$481,428→ 222,060 total - Sale
Common Stock
2025-02-14$8.05/sh−30,544$245,962→ 191,516 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 10-15-2024
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001681098
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:54 PM ET
- Size
- 6.1 KB